ClinicalTrials.Veeva
Menu

Find clinical trials for Breast Cancer in Salt Lake City, UT

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Triple Negative Breast Cancer
Cancer
Non-Small-Cell Lung Carcinoma
Ovarian Cancer
Neoplasm Metastasis
Squamous Cell Carcinoma of Head and Neck
Endometrial Cancer

Breast Cancer trials near Salt Lake City, UT, USA:

TALAVE: Induction Talazoparib Followed by Combination of Talazoparib and Avelumab in Advanced Breast Cancer

This is a multi-institutional pilot trial for patients with advanced breast cancer. The trial is designed to assess the safety and ...

Active, not recruiting
Breast Cancer
Drug: Avelumab
Drug: Talazoparib

Phase 1, Phase 2

Georgetown University
Georgetown University

Salt Lake City, Utah, United States and 1 other location

A phase 1 study of 68Ga-R11228 and 177Lu-R11228 in breast cancer....

Enrolling
Metastatic Hormone Receptor Positive Breast Cancer
Locoregionally Recurrent Hormone-receptor Positive Breast Cancer
Drug: 68Ga-R11228
Drug: 177Lu-R11228

Phase 1

Radionetics Oncology

Salt Lake City, Utah, United States and 6 other locations

A Phase 1 Dose Escalation and Expansion Study of AZD9833 Alone or in Combination in Women with ER Positive, HER2 Negative Advanced Breast Ca...

Active, not recruiting
ER+ HER2- Advanced Breast Cancer
Drug: AZD9833 with palbociclib
Drug: AZD9833 with capivasertib

Phase 1

AstraZeneca
AstraZeneca

Salt Lake City, Utah, United States and 16 other locations

to anti-HER2-based therapy plus endocrine therapy alone in improving the outcomes of subjects with hormone receptor-positive, HER2+ metastatic breast...

Active, not recruiting
Estrogen Receptor Positive Breast Cancer
HER-2 Positive Breast Cancer
Drug: palbociclib
Drug: trastuzumab

Phase 3

Alliance Foundation Trials

Salt Lake City, Utah, United States and 107 other locations

look at the efficacy and safety of trastuzumab deruxtecan (T-DXd) in a neoadjuvant setting, in high-risk, HER2-positive early non-metastatic breast...

Active, not recruiting
HER2-positive Early Breast Cancer
Breast Cancer
Drug: Pertuzumab
Drug: Paclitaxel

Phase 3

AstraZeneca
AstraZeneca

Ogden, Utah, United States and 145 other locations

to see if it can be a possible treatment for advanced metastatic breast cancer. This type of cancer would have spread from...

Active, not recruiting
Breast Cancer
Drug: vepdegestrant
Drug: PF-07220060

Phase 1, Phase 2

Pfizer
Pfizer

Salt Lake City, Utah, United States and 57 other locations

The purpose of this study is to test the safety of an investigational drug called CFI-402257 alone in advanced solid tumors and in combinati ...

Active, not recruiting
Breast Cancer
Advanced Solid Tumor
Drug: CFI-402257
Drug: Fulvestrant

Phase 1, Phase 2

Treadwell Therapeutics

West Valley City, Utah, United States and 3 other locations

This is a first-in-human study of MEN2312, a lysine acetyltransferase 6 (KAT6) inhibitor, in adult participants with advanced breast cancer...

Enrolling
Advanced Breast Cancer
Drug: Elacestrant
Drug: MEN2312

Phase 1

Stemline Therapeutics
Stemline Therapeutics

West Valley City, Utah, United States and 31 other locations

be open to the enrollment of patients diagnosed with triple-negative breast cancer or ovarian cancer. Dose expansion will ...

Enrolling
Metastatic Breast Cancer
Recurrent Ovarian Carcinoma
Drug: Belinostat
Drug: Ribociclib

Phase 1

Utah System of Higher Education (USHE)
Utah System of Higher Education (USHE)

Salt Lake City, Utah, United States and 1 other location

The purpose of this study is to test BTX-9341 alone or in combination with fulvestrant (a currently marketed medication for breast cancer...

Enrolling
Breast Cancer
Drug: Fulvestrant
Drug: BTX-9341

Phase 1

Biotheryx, Inc.

West Valley City, Utah, United States and 5 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems